by Paul Krzyzanowski | Jan 24, 2012
Repurposing known drugs for new applications is a strategy with fascinating potential, with two of the most notable examples being Thalidomide and Viagra. Thalidomide was commonly used in the late 1950s as a sedative in pregnant women, later being associated with...
by Stem Cell Network | Dec 14, 2011
When we report on breakthroughs in stem cell research, we typically link to well-funded studies published in peer-reviewed journals by world-renowned scientists. This time, it’s a little different. Angela Zhang, a high school senior from Cupertino, California, was...
by Lisa Willemse | Nov 8, 2011
Last week, Statistics Canada released a report with figures detailing the cause of death in which it noted that, for the first time, cancer had eclipsed heart disease as the leading cause of death in every province and territory in the country. According to the...
by Ben Paylor | Jun 17, 2011
Although elsewhere in Canada there are some very troubling consequences arising from a group not living up to their potential (I refer to the rioting hooligans and not the Canucks), the realization of potential happening here at the ISSCR couldn’t be more different....
by Ubaka Ogbogu | Apr 27, 2011
While preparing a consulting report on ethical issues associated with priority setting (a.k.a. resource allocation, rationing) in the stem cell research context, I was surprised to find that there are no published Canadian studies of priority-setting matters...
Comments